MedTrace Logo

Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients

NCT04932213 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2021-11-19

No results posted yet for this study

Summary

The aim of this study is to compare the effect of tropicamide 0.5% and tropicamide 1% on intraocular pressure and anterior chamber parameters in patients with Diabetes Mellitus.

Conditions

Interventions

DRUG

Tropicamide Ophthalmic

Tropicamide eye drops are used for dilating pupils (mydriasis) to do comprehensive fundus examination.

Sponsors & Collaborators

  • Semnan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Navid Elmi Sadr, MD · Semnan University of Medical Sciences, Semnan, Iran

  • Navid Elmi Sadr, MD · Semnan University of Medical Sciences, Semnan, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2021-11-07
Completion
2021-11-07

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932213 on ClinicalTrials.gov